Lassa fever
ICD-10 A32.0 is a billable code used to indicate a diagnosis of lassa fever.
Lassa fever is an acute viral hemorrhagic illness caused by the Lassa virus, a member of the Arenaviridae family. It is endemic in parts of West Africa, particularly in Nigeria, Sierra Leone, Liberia, and Guinea. The disease is primarily transmitted to humans through contact with the urine or feces of infected Mastomys rats, which are common in these regions. Symptoms typically appear 1-3 weeks after exposure and can range from mild to severe, including fever, weakness, headaches, and gastrointestinal symptoms. In severe cases, Lassa fever can lead to hemorrhagic manifestations, multi-organ failure, and death. Diagnosis is often confirmed through serological testing or PCR. Treatment primarily involves supportive care, and the antiviral drug ribavirin has shown efficacy if administered early in the course of the disease. Preventive measures focus on rodent control and minimizing contact with potentially infected materials. Due to its potential for outbreaks and public health implications, Lassa fever is a significant concern in endemic regions.
Detailed patient history, including travel and exposure history, laboratory results, and clinical symptoms.
Patients presenting with fever and travel history to endemic regions, suspected cases of viral hemorrhagic fever.
Ensure accurate documentation of laboratory tests and clinical findings to support the diagnosis.
Immediate assessment of symptoms, travel history, and initial laboratory tests.
Patients presenting with acute febrile illness after travel to West Africa.
Rapid identification and documentation of potential exposure to facilitate timely treatment.
Used for confirming Lassa fever through PCR testing.
Document the reason for testing and the patient's travel history.
Infectious disease specialists should ensure comprehensive documentation of clinical findings.
Primary symptoms include fever, weakness, headaches, vomiting, and in severe cases, bleeding and multi-organ failure.
Diagnosis is confirmed through serological testing or PCR, along with a thorough patient history of exposure.
